Identifying Entrepreneurial Opportunities with Mark Newman, Nomi Health, moderated by Ben Capell Artwork

Running Stuff, a Peterson Partners podcast

Successful entrepreneurs are wired differently. They are Changemakers. Running Stuff, a Peterson Partners podcast, aims to uncover the real story of what it’s like in the trenches to run and scale a business. Running Stuff combines the wisdom and success of Stanford University Professor, and former JetBlue Airways Chairman, Joel Peterson with some of today's brightest entrepreneurs to provide insight on how to “Run Stuff.”Join us for season one where we will discuss topics every entrepreneur should know but might be hesitant to ask including, how to start from scratch, how to go to market, how to hire the right people, and how to develop a differentiated brand.

All Episodes

Running Stuff, a Peterson Partners podcast

Identifying Entrepreneurial Opportunities with Mark Newman, Nomi Health, moderated by Ben Capell

September 01, 2021 • Peterson Partners • Season 1 • Episode 13

Our topic in this episode is identifying entrepreneurial opportunities and our guest is Mark Newman. Mark is a multiple-time entrepreneur. He was the co-founder and former CEO of HireVue and is currently the co-founder and CEO of Nomi Health as well as the Co-founder and board member at Videra Health. Mark has the ability to identify opportunities where others only see problems and continually find solutions where others only see obstacles. Mark earned an M.S. in Finance from the University of Utah and B.A. in International Business from Westminster College in Salt Lake City, Utah. We are excited to have Mark share some of the lessons he's learned as a founder and CEO over the last 17 years.

The portfolio companies identified and described herein do not represent all of the portfolio companies purchased, sold or recommended for funds advised by Peterson Partners. The reader should not assume that an investment in the portfolio companies identified was or will be profitable. Any opinions, projections, forecasts and estimates contained in this production are necessarily speculative in nature, are based upon certain assumptions, and subject to change without notice. It can be expected that some or all of such assumptions will not materialize or will vary significantly from actual results. This production is not an offer to buy or sell any investments. Past performance is not indicative of future results.